GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » Altman Z-Score

Sinohealth Holdings (HKSE:02361) Altman Z-Score : 13.03 (As of Dec. 13, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 12.8 is strong.

Sinohealth Holdings has a Altman Z-Score of 13.03, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Sinohealth Holdings's Altman Z-Score or its related term are showing as below:

HKSE:02361' s Altman Z-Score Range Over the Past 10 Years
Min: 12.8   Med: 14.82   Max: 15.29
Current: 12.8

During the past 5 years, Sinohealth Holdings's highest Altman Z-Score was 15.29. The lowest was 12.80. And the median was 14.82.


Sinohealth Holdings Altman Z-Score Historical Data

The historical data trend for Sinohealth Holdings's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinohealth Holdings Altman Z-Score Chart

Sinohealth Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
- - - 14.35 15.29

Sinohealth Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only - 14.35 - 15.29 -

Competitive Comparison of Sinohealth Holdings's Altman Z-Score

For the Health Information Services subindustry, Sinohealth Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinohealth Holdings's Altman Z-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Sinohealth Holdings's Altman Z-Score falls into.



Sinohealth Holdings Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Sinohealth Holdings's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.6581+1.4*0.3978+3.3*0.1396+0.6*17.8763+1.0*0.4966
=13.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was HK$872.6 Mil.
Total Current Assets was HK$666.4 Mil.
Total Current Liabilities was HK$92.2 Mil.
Retained Earnings was HK$347.1 Mil.
Pre-Tax Income was HK$121.1 Mil.
Interest Expense was HK$-0.7 Mil.
Revenue was HK$433.3 Mil.
Market Cap (Today) was HK$1,902.2 Mil.
Total Liabilities was HK$106.4 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(666.4 - 92.163)/872.552
=0.6581

X2=Retained Earnings/Total Assets
=347.098/872.552
=0.3978

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(121.126 - -0.7)/872.552
=0.1396

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1902.213/106.41
=17.8763

X5=Revenue/Total Assets
=433.349/872.552
=0.4966

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Sinohealth Holdings has a Altman Z-Score of 13.03 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Sinohealth Holdings  (HKSE:02361) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Sinohealth Holdings Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinohealth Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Executives
Futu Trustee Limited 2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd 2201 Interest of corporation controlled by you
Yu Rong 2201 Interest of corporation controlled by you
Tianyi (bvi) Limited 2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang 2201 Interest of corporation controlled by you
Wu Yushu 2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited 2101 Beneficial owner
Li Hanxiong 2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd 2101 Beneficial owner
Wu Meirong 2202 Interest of your spouse
Ying Lian You Xian Gong Si 2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines